Combination therapies for B-cell lymphomas comprising administration of antiCD20 antibody

Details for Australian Patent Application No. 2008207357 (hide)

International Classifications

Event Publications

4 September 2008 Application Open to Public Inspection

Published as AU-B-2008207357

4 September 2008 Complete Application Filed

9 April 2009 Alteration of Name

The name of the applicant has been altered to Biogen Idec Inc.

14 July 2011 Application Accepted

Published as AU-B-2008207357

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.